1.9(top 20%)
impact factor
1.5K(top 20%)
papers
23.5K(top 10%)
citations
59(top 10%)
h-index
2.0(top 20%)
impact factor
1.9K
all documents
26.3K
doc citations
83(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Has the time come for a staging model to map the course of eating disorders from high risk to severe enduring illness? An examination of the evidenceMicrobial Biotechnology2015234
2Social media and suicide prevention: a systematic reviewMicrobial Biotechnology2016217
3Age at onset and the outcomes of schizophrenia: A systematic review and meta‐analysisMicrobial Biotechnology2017192
4Review of the operational definition for first‐episode psychosisMicrobial Biotechnology2009186
5Evaluating an individualized lifestyle and life skills intervention to prevent antipsychotic‐induced weight gain in first‐episode psychosisMicrobial Biotechnology2016177
6Applying clinical staging to young people who present for mental health careMicrobial Biotechnology2013173
7Prevention and early intervention to improve mental health in higher education students: a reviewMicrobial Biotechnology2010170
8The effectiveness of school mental health literacy programs to address knowledge, attitudes and help seeking among youthMicrobial Biotechnology2013167
9Beliefs about appropriate first aid for young people with mental disorders: findings from an Australian national survey of youth and parentsMicrobial Biotechnology2007149
10Mental health literacy in higher education studentsMicrobial Biotechnology2012144
11Mental Health First Aid: an international programme for early interventionMicrobial Biotechnology2008141
12Resilience as a multimodal dynamic processMicrobial Biotechnology2019135
13Australia's innovation in youth mental health care: The headspace centre modelMicrobial Biotechnology2019133
14Epidemiological factors associated with treated incidence of first‐episode non‐affective psychosis in Cantabria: insights from the Clinical Programme on Early Phases of PsychosisMicrobial Biotechnology2008131
15Antipsychotic‐induced weight gain in first‐episode psychosis patients: a meta‐analysis of differential effects of antipsychotic medicationsMicrobial Biotechnology2016128
16Youth at ultra high risk for psychosis: using the Revised Network Episode Model to examine pathways to mental health careMicrobial Biotechnology2013126
17Cognitive remediation in schizophrenia: efficacy and effectiveness in patients with early versus long‐term course of illnessMicrobial Biotechnology2014126
18Role of social media and the Internet in pathways to care for adolescents and young adults with psychotic disorders and non‐psychotic mood disordersMicrobial Biotechnology2017124
19Stigma and treatment delay in first‐episode psychosis: a grounded theory studyMicrobial Biotechnology2010120
20Children's experiences of parental mental illness: a literature reviewMicrobial Biotechnology2011112
21Providing online support for young people with mental health difficulties: challenges and opportunities exploredMicrobial Biotechnology2008111
22Parent and family factors associated with service use by young people with mental health problems: a systematic reviewMicrobial Biotechnology2015103
23Moderated online social therapy for depression relapse prevention in young people: pilot study of a ‘next generation’ online interventionMicrobial Biotechnology2018102
24The First‐Episode Psychosis Outcome Study: premorbid and baseline characteristics of an epidemiological cohort of 661 first‐episode psychosis patientsMicrobial Biotechnology2007100
25Early traumatic experiences in those at clinical high risk for psychosisMicrobial Biotechnology201395
26Pilot study of a mindfulness‐based, multi‐component, in‐school group sleep intervention in adolescent girlsMicrobial Biotechnology201394
27Trajectory to a first episode of psychosis: a qualitative research study with familiesMicrobial Biotechnology200792
28Treatment and Early Intervention in Psychosis Program (TIPP‐Lausanne): implementation of an early intervention programme for psychosis in SwitzerlandMicrobial Biotechnology201392
29Exercise as an intervention for first‐episode psychosis: a feasibility studyMicrobial Biotechnology201891
30A descriptive review of qualitative studies in first episode psychosisMicrobial Biotechnology201089
31Early identification and treatment of eating disorders: prodrome to syndromeMicrobial Biotechnology200787
32Substance use in clinical high risk for psychosis: a review of the literatureMicrobial Biotechnology201484
33The arrival of preemptive psychiatryMicrobial Biotechnology200783
34The heart of the matter: cardiometabolic care in youth with psychosisMicrobial Biotechnology201282
35Exploring opportunities to support mental health care using social media: A survey of social media users with mental illnessMicrobial Biotechnology201981
36Effectiveness of individual placement and support supported employment for young adultsMicrobial Biotechnology201678
37A systematic review on definitions and assessments of psychotic‐like experiencesMicrobial Biotechnology201678
38Broad clinical high‐risk mental state (CHARMS): Methodology of a cohort study validating criteria for pluripotent riskMicrobial Biotechnology201976
39Young people's views of UK mental health servicesMicrobial Biotechnology201475
40From research to practice: how OPUS treatment was accepted and implemented throughout DenmarkMicrobial Biotechnology201574
41Can an Internet‐based intervention reduce suicidal ideation, depression and hopelessness among secondary school students: results from a pilot studyMicrobial Biotechnology201673
42Stigma in families of individuals in early stages of psychotic illness: family stigma and early psychosisMicrobial Biotechnology200971
43Clinical benefits and impact of early use of long‐acting injectable antipsychotics for schizophreniaMicrobial Biotechnology201671
44Role of inflammation in the pathogenesis of schizophrenia: A review of the evidence, proposed mechanisms and implications for treatmentMicrobial Biotechnology202071
45Psychosis risk screening in different populations using the Prodromal Questionnaire: A systematic reviewMicrobial Biotechnology201870
46Social cognition deficits and the ‘ultra high risk’ for psychosis population: a review of literatureMicrobial Biotechnology201168
47Canadian response to need for transformation of youth mental health services: ACCESS Open Minds (Esprits ouverts)Microbial Biotechnology201967
48Prodromal stage of major depressionMicrobial Biotechnology200766
49Defining, operationalizing and measuring the duration of untreated psychosis: advances, limitations and future directionsMicrobial Biotechnology200766
50Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first‐episode schizophreniaMicrobial Biotechnology201566